search
Back to results

Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study

Primary Purpose

Muscle Atrophy, Surgery, Knee Injuries and Disorders

Status
Unknown status
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Aveed 750 MG in 3 ML IM Injection
Normal Saline 3 ML IM Injection
Sponsored by
The Stone Research Foundation for Sports Medicine and Arthritis
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Muscle Atrophy focused on measuring Surgery, Testosterone, Muscle atrophy, Post-operative rehabilitation

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Males age 18-65.
  • Undergoing significant knee surgery such as partial/total knee replacement, ligament reconstruction, meniscus surgeries or articular cartilage paste grafting.

Exclusion Criteria:

  • Men with carcinoma of the breast or known or suspected carcinoma of the prostate.
  • Men with BMI > 30 and Type I or II diabetes diagnosis
  • Men prone to deep vein thrombosis or sleep apnea.
  • Men with pre-existing hematocrit abnormalities.
  • Men with pre-existing cardiac, renal, hepatic disease.
  • Men who are taking insulin, medicines that decrease blood clotting or corticosteroids.
  • Men with known hypersensitivity to testosterone undecanoate or any of its formulation ingredients (testosterone, refined castor oil, benzyl benzoate).
  • Subject's unable or unwilling to comply with the protocol.
  • Subject's unable to provide informed consent.
  • Subject's unable to understand verbal and/or written English.

Sites / Locations

  • Stone Research Foundation

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Testosterone Group

Control Group

Arm Description

Participants receiving two IM Testosterone injections.

Participants receiving two IM Normal Saline Injections.

Outcomes

Primary Outcome Measures

Change in MRI Cross Sectional Area of the Quadriceps
T1 Axial and Sagittal planes will be obtained using a ONI 1.0T extremity MRI. Axial Cross sectional Area (cm^2) will be measured of the Quadriceps muscle.
Change in Manual Measurements of the Quadriceps
Manual measurement of the quadriceps muscle will be performed 8-cm proximal to the superior-patella using a standard cm measuring tape.

Secondary Outcome Measures

Change in Knee Pain and Function Survey, KOOS
Evaluate the knee pain and function of subjects as measures by the KOOS assessment. Sections: Pain Symptoms Activities of Daily Living Sports and Recreation Quality of Life Scoring: Each subscale score is calculated independently. The mean score of the individual items of each subscale is calculated and divided by 4 (the highest possible score for a single answer option). Traditionally in orthopedics, 100 indicates no problems and 0 indicates extreme problems. The normalized score is transformed to meet this standard.

Full Information

First Posted
June 24, 2020
Last Updated
August 30, 2021
Sponsor
The Stone Research Foundation for Sports Medicine and Arthritis
search

1. Study Identification

Unique Protocol Identification Number
NCT04456530
Brief Title
Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study
Official Title
Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Unknown status
Study Start Date
May 8, 2020 (Actual)
Primary Completion Date
December 30, 2021 (Anticipated)
Study Completion Date
June 30, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The Stone Research Foundation for Sports Medicine and Arthritis

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes

5. Study Description

Brief Summary
The loss of muscle mass post-surgery confounds recovery efforts and leads to a delay in patient's ability to return to activities. Although the use of testosterone in aging and chronic muscle loss has been investigated, this study could prove short-term use of testosterone efficacious in preventing muscle atrophy due to surgery. We hypothesize that by bracketing an indexed knee surgery with testosterone undecanoate injections, post-surgical quadriceps muscle loss may be minimized. Determination of the effect of intra-muscular (IM) testosterone injections in preventing quadriceps muscle loss are measured by serial MRI and manual measurements of quadriceps cross-section.
Detailed Description
This is an in vivo study using serial IM testosterone undeconate injections in participants undergoing knee surgery with limited weight bearing post-operatively which includes partial/total knee replacement, ACL reconstruction/revision, meniscal allograft transplantation and articular cartilage paste grafting. The design is a randomized, controlled, double blind, longitudinal study of intra-muscular injections of testosterone versus saline control. Pre-operative and post-operative assessments will include: serial MRIs and manual measurements of quadriceps cross-section and knee pain and function survey, KOOS. Blood analysis will be performed for therapeutic assessment and safety. The participant will receive two testosterone undeconate injections, once during their pre-operative visit and once during their 1 month visit. Timing of assessments will be pre-operative, 1-4 days post-operative and 1, 3, and 6 months. Measurement of the control group versus experimental group at all time points may identify differences in participant response to testosterone injections.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Muscle Atrophy, Surgery, Knee Injuries and Disorders, Complication of Surgical Procedure, Trauma
Keywords
Surgery, Testosterone, Muscle atrophy, Post-operative rehabilitation

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Masking Description
Both the participant and analyzing MRI Radiologist will be blind.
Allocation
Randomized
Enrollment
15 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Testosterone Group
Arm Type
Experimental
Arm Description
Participants receiving two IM Testosterone injections.
Arm Title
Control Group
Arm Type
Placebo Comparator
Arm Description
Participants receiving two IM Normal Saline Injections.
Intervention Type
Drug
Intervention Name(s)
Aveed 750 MG in 3 ML IM Injection
Intervention Description
Participants in the Testosterone Group will receive two IM Aveed injections 1 month apart.
Intervention Type
Other
Intervention Name(s)
Normal Saline 3 ML IM Injection
Intervention Description
Participants in the Control Group will receive two IM normal saline injections 1 month apart.
Primary Outcome Measure Information:
Title
Change in MRI Cross Sectional Area of the Quadriceps
Description
T1 Axial and Sagittal planes will be obtained using a ONI 1.0T extremity MRI. Axial Cross sectional Area (cm^2) will be measured of the Quadriceps muscle.
Time Frame
Pre-operative and 1, 3, and 6 months post-operative
Title
Change in Manual Measurements of the Quadriceps
Description
Manual measurement of the quadriceps muscle will be performed 8-cm proximal to the superior-patella using a standard cm measuring tape.
Time Frame
Pre-operative and 1, 3, and 6 months post-operative
Secondary Outcome Measure Information:
Title
Change in Knee Pain and Function Survey, KOOS
Description
Evaluate the knee pain and function of subjects as measures by the KOOS assessment. Sections: Pain Symptoms Activities of Daily Living Sports and Recreation Quality of Life Scoring: Each subscale score is calculated independently. The mean score of the individual items of each subscale is calculated and divided by 4 (the highest possible score for a single answer option). Traditionally in orthopedics, 100 indicates no problems and 0 indicates extreme problems. The normalized score is transformed to meet this standard.
Time Frame
Pre-operative and 1, 3, and 6 months post-operative
Other Pre-specified Outcome Measures:
Title
Change in serum cortisol (mcg/dL) levels
Description
Laboratory blood analysis of cortisol will be performed for therapeutic assessment and safety.
Time Frame
Pre-operative, 1-4 days post-operative and 1 month and 3 months post-operative
Title
Change in serum testosterone (ng/dL) levels
Description
Laboratory blood analysis of testosterone will be performed for therapeutic assessment and safety.
Time Frame
Pre-operative, 1-4 days post-operative and 1 month and 3 months post-operative
Title
Change in serum prostate specific antigen (ng/mL) levels
Description
Laboratory blood analysis of PSA will be performed for therapeutic assessment and safety.
Time Frame
Pre-operative, 1-4 days post-operative and 1 month and 3 months post-operative
Title
Change in serum hepatic function panel (mg/dL) levels
Description
Laboratory blood analysis of HFP will be performed for therapeutic assessment and safety.
Time Frame
Pre-operative, 1-4 days post-operative and 1 month and 3 months post-operative
Title
Change in complete blood count with differential levels
Description
Laboratory blood analysis CBC w/ diff will be performed for therapeutic assessment and safety.
Time Frame
Pre-operative, 1-4 days post-operative and 1 month and 3 months post-operative

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Males age 18-65. Undergoing significant knee surgery such as partial/total knee replacement, ligament reconstruction, meniscus surgeries or articular cartilage paste grafting. Exclusion Criteria: Men with carcinoma of the breast or known or suspected carcinoma of the prostate. Men with BMI > 30 and Type I or II diabetes diagnosis Men prone to deep vein thrombosis or sleep apnea. Men with pre-existing hematocrit abnormalities. Men with pre-existing cardiac, renal, hepatic disease. Men who are taking insulin, medicines that decrease blood clotting or corticosteroids. Men with known hypersensitivity to testosterone undecanoate or any of its formulation ingredients (testosterone, refined castor oil, benzyl benzoate). Subject's unable or unwilling to comply with the protocol. Subject's unable to provide informed consent. Subject's unable to understand verbal and/or written English.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mani Vessal, Ph.D.
Organizational Affiliation
Stone Research Foundation
Official's Role
Study Director
Facility Information:
Facility Name
Stone Research Foundation
City
San Francisco
State/Province
California
ZIP/Postal Code
94123
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
19707253
Citation
Bassil N, Alkaade S, Morley JE. The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag. 2009 Jun;5(3):427-48. doi: 10.2147/tcrm.s3025. Epub 2009 Jun 22.
Results Reference
background
PubMed Identifier
984911
Citation
Nicholas JJ, Taylor FH, Buckingham RB, Ottonello D. Measurement of circumference of the knee with ordinary tape measure. Ann Rheum Dis. 1976 Jun;35(3):282-4. doi: 10.1136/ard.35.3.282.
Results Reference
background
PubMed Identifier
9353686
Citation
Arangio GA, Chen C, Kalady M, Reed JF 3rd. Thigh muscle size and strength after anterior cruciate ligament reconstruction and rehabilitation. J Orthop Sports Phys Ther. 1997 Nov;26(5):238-43. doi: 10.2519/jospt.1997.26.5.238.
Results Reference
background
PubMed Identifier
25358592
Citation
Marcon M, Ciritsis B, Laux C, Nanz D, Nguyen-Kim TD, Fischer MA, Andreisek G, Ulbrich EJ. Cross-sectional area measurements versus volumetric assessment of the quadriceps femoris muscle in patients with anterior cruciate ligament reconstructions. Eur Radiol. 2015 Feb;25(2):290-8. doi: 10.1007/s00330-014-3424-2. Epub 2014 Oct 31.
Results Reference
background
PubMed Identifier
25278072
Citation
Ruhdorfer AS, Dannhauer T, Wirth W, Cotofana S, Roemer F, Nevitt M, Eckstein F; OAI investigators. Thigh muscle cross-sectional areas and strength in knees with early vs knees without radiographic knee osteoarthritis: a between-knee, within-person comparison. Osteoarthritis Cartilage. 2014 Oct;22(10):1634-8. doi: 10.1016/j.joca.2014.06.002.
Results Reference
background
PubMed Identifier
26268693
Citation
Orgiu S, Lafortuna CL, Rastelli F, Cadioli M, Falini A, Rizzo G. Automatic muscle and fat segmentation in the thigh from T1-Weighted MRI. J Magn Reson Imaging. 2016 Mar;43(3):601-10. doi: 10.1002/jmri.25031. Epub 2015 Aug 13.
Results Reference
background
PubMed Identifier
15248788
Citation
Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513-54. doi: 10.2165/00007256-200434080-00003.
Results Reference
background
PubMed Identifier
9604196
Citation
Irrgang JJ, Ho H, Harner CD, Fu FH. Use of the International Knee Documentation Committee guidelines to assess outcome following anterior cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc. 1998;6(2):107-14. doi: 10.1007/s001670050082.
Results Reference
background
PubMed Identifier
1285753
Citation
Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992 Jul 18;305(6846):160-4. doi: 10.1136/bmj.305.6846.160.
Results Reference
background
PubMed Identifier
12366624
Citation
Amory JK, Chansky HA, Chansky KL, Camuso MR, Hoey CT, Anawalt BD, Matsumoto AM, Bremner WJ. Preoperative supraphysiological testosterone in older men undergoing knee replacement surgery. J Am Geriatr Soc. 2002 Oct;50(10):1698-701. doi: 10.1046/j.1532-5415.2002.50462.x.
Results Reference
background
PubMed Identifier
2917954
Citation
Griggs RC, Kingston W, Jozefowicz RF, Herr BE, Forbes G, Halliday D. Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol (1985). 1989 Jan;66(1):498-503. doi: 10.1152/jappl.1989.66.1.498.
Results Reference
background
PubMed Identifier
15827765
Citation
Akima H, Furukawa T. Atrophy of thigh muscles after meniscal lesions and arthroscopic partial menisectomy. Knee Surg Sports Traumatol Arthrosc. 2005 Nov;13(8):632-7. doi: 10.1007/s00167-004-0602-9. Epub 2005 Apr 13.
Results Reference
background
PubMed Identifier
28840147
Citation
Wu B, Lorezanza D, Badash I, Berger M, Lane C, Sum JC, Hatch GF 3rd, Schroeder ET. Perioperative Testosterone Supplementation Increases Lean Mass in Healthy Men Undergoing Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial. Orthop J Sports Med. 2017 Aug 9;5(8):2325967117722794. doi: 10.1177/2325967117722794. eCollection 2017 Aug.
Results Reference
background
Links:
URL
https://www.endo.com/File%20Library/Products/Prescribing%20Information/AVEED_prescribing_information.html
Description
Aveed Prescribing Information

Learn more about this trial

Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study

We'll reach out to this number within 24 hrs